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Antibiotic Resistance in Biofilm
Sadık Dincer, Fatima Masume Uslu and Anil Delik
Abstract
Biofilms can be found on several living and nonliving surfaces, which are 
formed by a group of microorganisms, complex assembly of proteins, polysac-
charides, and DNAs in an extracellular polymeric matrix. By forming a biofilm, 
bacteria protect themselves from host defense, disinfectants, and antibiotics. 
Bacteria inside biofilm are much more resistant to antimicrobial agents than 
planktonic forms since bacteria that are unresisting to antimicrobial agents in 
any way can turn resistant after forming a biofilm. Low penetration of antibiotics 
into the biofilm, slow reproduction, and the existence of adaptive stress response 
constitute the multiphased defense of the bacterium. This antibiotic resistance, 
which is provided by biofilm, makes the treatments, which use effective antibiotic 
doses on the bacterium in planktonic shape, difficult. Biofilm formation potential 
of bacteria appears as an important virulence factor in ensuring the colonization 
on the living tissues or medical devices and makes the treatment difficult. The aim 
of this chapter is to overview the current knowledge of antimicrobial resistance 
mechanisms in biofilms.
Keywords: biofilm, antibiotic resistance, bacteria, antimicrobial agents
1. Introduction
Bacteria can grow in biofilms on a wide variety of surfaces and attach to inert 
or alive surfaces, including tissues, industrial surfaces, and artificial devices, 
such as catheters, intrauterine contraceptive devices, and prosthetic medical 
devices, implants, cardiac valves, dental materials, and contact lenses [1, 2]. 
Biofilm growth confers several advantages to bacteria, including protective 
against hostile environments conditions such as osmotic stress, metal toxicity, 
and antibiotic exposure.
Biofilm-associated drug resistance and tolerance play a major role in the 
pathogenesis of many subacute and chronic bacterial diseases and their recalci-
trance to antibiotic treatment, especially in medical device-related infections.
The definition of biofilm has been made with the development of new tech-
niques for the direct examination of biofilms over the last four decades. Initially, 
a biofilm was defined as the composition of bacterial communities bound to 
coated surfaces in a glycocalyx matrix; subsequently, the correct definition of 
biofilm was made not only by considering its easily observable properties, such as 
cells irreversibly attached to a surface or interface embedded in an extracellular 
polymeric matrix material, but also by taking into account other physiological 
properties of these organisms such as altered growth rate and different gene 
expression [3].
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A biofilm can be described as a microbially derived sessile community character-
ized by cells. These cells are irreversibly attached to a surface or interface or to each 
other, are inserted in a matrix of extracellular polymeric substances (EPSs) that 
they have produced, and exhibit an altered phenotype in terms of growth rate and 
gene transcription [4].
EPSs consist of proteins, cellulose, alginates, extracellular teichoic acid, poly-N-
acetyl, and other organic compounds [4, 5] and play a critical role in the formation 
of glucosamine, lipids, nucleic acids, phospholipids, polysaccharides, and extracel-
lular DNA (eDNA) and in physical interactions [4].
The stages that occur during the biofilm development are the initial attachment 
of the planktonic cell to the surface, followed by cell differentiation, EPS secretion, 
maturation, and dispersion of biofilm [6]. It can be summarized in three main 
stages: irreversible adhesion to the surface, being followed by bacterial division 
and production of the extracellular matrix, and, finally, disassembly of the matrix 
and dispersion of bacteria [2]. Quorum Sensing (QS) is one of the regulatory 
mechanisms that plays an important role in coordinating biofilm formation in 
many species but QS may not be the primary regulatory mechanism and serves as a 
checkpoint during the development of biofilm [6].
2. Causes of antibiotic failure in biofilm
Antibiotic resistance is the acquired ability of a microorganism to resist the 
effect of an antimicrobial agent and is associated with inheritable antibiotic 
resistance. On the other hand, antibiotic tolerance is a transient and nonheritable 
phenotype defined by the physiological state of biofilm cell populations. Also it 
can be provided by biofilm-specific characteristics that limit drug diffusion and 
activity [7]. For an antimicrobial agent to act on biofilm-forming microorganisms, 
it must overcome some factors, such as an increased number of resistant mutants, 
high cell density, molecular exchanges, substance delivery, efflux pump, and 
persistent cells.
2.1 Antibiotic penetration
Antibiotic molecules ought to penetrate throughout the biofilm matrix to impact 
the covered cells. The extracellular polymeric matrix influences the amount of the mol-
ecule, which is transferred to the inner layer of biofilm and interacts with an antibiotic 
agent, so it provides an anti-spread barrier for an antimicrobial agent. Biofilm EPS 
confers a physical barrier containing numerous anionic and cationic molecules such 
as proteins, glycoproteins, and glycolipid that can bind charged antimicrobial agents 
and provide shelter for microorganisms [8]. For example in Pseudomonas aeruginosa 
biofilms, Pel exopolysaccharides, an EPS component is able to spread cationic antibiot-
ics such as aminoglycosides and, thus, provides tolerance to these molecules [9].
The adsorption sites of the matrix also limit the transportation of antimicrobial 
substances. Glycocalyx layer, component of EPS, can accumulate antibacterial 
molecule up to 25% of its weight and serve as an adherent for exoenzymes [10].
It is commonly accepted that in written materials lowered antibiotic penetration 
toward the EPS layer does not adequately clarify the risen resistance of microor-
ganisms forming biofilm against most antimicrobial agents. The act of lowered 
antibiotic penetration in developing biofilm is not clear due to the fact that even 
antibiotics, which quickly disperse the biofilm, do not lead to notable cell death. 
It is suggested that reduction of antibiotics penetration might provide time for an 
adaptive phenotypic response, which can probably reduce susceptibility [11].
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2.2 Accumulation of antibiotic-degrading enzymes in the matrix
The microorganisms that form biofilm are able to collect high amounts of 
β-lactamases in the biofilm matrix as a defense mechanism.
When P. aeruginosa biofilm matrix accumulates β-lactamases, it can lead 
to increased hydrolysis of antibiotics, such as imipenem and ceftazidime. It is 
demonstrated that P. aeruginosa PAO1-J32 biofilms have shown high promoter 
(ampC β-lactamases) activity, which is determined by scanning confocal laser 
photomicrographs [12]. Also, while ampicillin cannot reach the deeper layers of 
Klebsiella pneumoniae biofilms associated with β-lactamase activity, deletion of 
β-lactamase increases the amount of ampicillin that reaches the deep layer [13].
2.3 DNA in biofilm matrix
Extracellular DNA (eDNA) is a significant and common component ingredient 
of the bacterial biofilm matrix. The eDNA can be obtained endogenously without 
quorum sensing-mediated release, from the outer membrane or from the cell 
integrity-degraded biofilm microorganisms [14]. DNA can increase biofilm resis-
tance to certain antimicrobial agents [15].
One of the mechanisms by which the DNA increases biofilm resistance is that it 
causes changes in outer membrane because DNA is an anionic molecule; it is able to 
chelate cations, such as magnesium ions and cause a lowering Mg2+ concentration in 
membrane. Magnesium restriction in P. aeruginosa and Salmonella enterica serovar 
Typhimurium is an environmental signal that induces energizing of the two-com-
ponent systems PhoPQ and PmrAB to provide antimicrobial resistance [16].
These signal molecules are responsible for the rearrangement of the PA3552-3559 
operon. The operon encodes to protein having enzymatic activity that attaches ami-
noarabinose to Lipid A part of the lipopolysaccharide layer, so it provides resistance 
against cationic peptide and aminoglycoside [17].
A polyamine, spermidine, localized to the outer membrane contributes to saving 
the cell from aminoglycosides and cationic peptides that are antimicrobial agents 
by lowering outer membrane penetrability for these positively charged molecules. 
Spermidine synthesis is another resistance mechanism induced by eDNA-associated 
cation restriction in P. aeruginosa [18].
Playing a physical role in defense against antibiotics, eDNA has also provided 
horizontal transfer of antibiotic resistance genes between microorganism cells 
forming biofilm [14].
2.4 Growth rate, stress response, and persistent cells
During growth in biofilm structures, physiological heterogeneity happens due to 
the occurrence of oxygen and other nutrients gradient in biofilms. This gradient is 
created because cells that are close to the surface of the biofilm consume obtainable 
nutrient sources and oxygen before the nutrients disperse into depth of the biofilm 
[19]. Nutrient and oxygen concentration gradients develop and cause bacterial 
populations that display different growth rates [20]. The effect of many antibiotics 
depends on growth. Because most antibiotics aim at some kind of produced macro-
molecule, it is unexpected that these agents will have much impact on the microor-
ganisms in biofilm that limit macromolecular production, so conventional antibiotics 
are usually less affected against metabolically inactive or slow-growing cells.
In biofilms, a small subpopulation of bacteria can be reversibly transformed into 
slowly growing cells. These cells are known as persistent or dormant cells. Persistent 
cells are generated stochastically or under endogenous stress (e.g., oxidative stress 
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and exposure to antibiotics) and are highly resistant to being killed by antibiotics 
[21, 22]. When these cells are compared with active and rapidly growing bacteria, 
lower metabolism rate makes these cells less susceptible to antibiotics. High levels of 
persistent cells are seen in chronic urinary tract infections and the lungs of patients 
with cystic fibrosis, especially, when the penetration of the immune system com-
ponents is limited. The dormant phenotype is characterized by down-regulation of 
functions, such as energy production and biosynthesis.
Persistent formation is enhanced by toxin/antitoxin (TA) systems induced by 
environmental factors or DNA damage. TA systems do the following: (i) inhibition 
of protein synthesis by phosphorylation of the elongation factor, Ef-Tu (e.g., HipBA), 
translation inhibition and subsequent tolerance to antibiotics; (ii) expressing the TA 
modules (e.g., TisB toxin forming an anion channel in the membrane) leading to a 
decrease in PMF and ATP levels; and (iii) breakdown of mRNA (e.g., RelE and MazF 
toxins) and inhibition of translation. Prolonged treatment with aminoglycosides 
and RNA polymerase inhibitor rifampicin may prevent persistent resuscitation with 
synergistic effects with TA systems [23]. It is suggested that fluoroquinolones can 
induce TisB toxin by causing DNA damage in Escherichia coli [24]. In biofilms, many 
TA systems are associated with multidrug-tolerant persistent cells. However, this 
tolerance is limited to specific antibiotics and TA [25].
Bacteria are equipped with a range of stress responses that make them possible 
to deal with environmental change, such as oxidative stress, unexpected tempera-
ture changes, low water activity, deprivation, and DNA damage [26]. These adap-
tive responses serve to enhance bacterial survivability. Adaptive stress responses 
can influence antimicrobial susceptibility since these responses impact on many of 
the same cellular components and processes that are aimed by antimicrobials [27].
Heterogeneity in the biofilm is one of the causes of the stress response. [26]. 
Cells within hypoxic zones have decreased metabolic activity and are in a state like 
stationary phase [28]. It is known that many of the stress responses result in bacte-
rial cells entering stationary phase.
Nutrient starvation also induces (p)ppGpp production, which mediates a global 
stress response known as the stringent response. The stringent response and (p)
ppGpp signaling contribute to multidrug tolerance in P. aeruginosa biofilms. It 
is shown that ofloxacin, gentamicin, meropenem, and colistin killing increased 
upon inactivation of the stringent response [29]. Nutrient starvation also induced 
ofloxacin tolerance in E. coli K-12 biofilm through mechanisms dependent on the 
stringent and SOS response [30].
2.5 Quorum sensing
Despite their self-sufficiency, bacteria interact with neighbors to accomplish 
collective activities, such as bioluminescence production, biofilm development, and 
exoenzyme secretion. This cooperation occurs through a mechanism: quorum sens-
ing (QS) [31]. Quorum sensing (QS) is cell-to-cell communication at the molecular 
level controlled by chemical signaling molecules called autoinducers (AIs) [32]. Due 
to QS, bacteria can recognize the population density by measuring the accumula-
tion of signaling molecules that are secreted from members of the community. The 
accumulation of the signal in the extracellular environment is adequate to activate 
the response only when the population density is high [33].
Recent studies indicate that in many bacterial species, activation of QS happens 
in the formed biofilm activating the maturation and disassembly of the biofilm. The 
initial adhesion step seems not suitable for the accumulation of signal molecules. 
Then, with the next steps, the attached bacteria are divided and form microcolo-
nies, population density rises, and so signal molecules can reach adequate levels 
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to activate the maturation and disassembly of the biofilm in a coordinate manner 
(Figure 1). The time nutrients and other resources become limited and waste 
products accumulate, biofilm dispersion is imperative to provide bacteria to escape 
and colonize new niches [33].
P. aeruginosa harbors two complete AHL circuits, lasI/lasR and rhlI/rhlR, the 
lasI/R circuit being hierarchically positioned upstream, of the rhlI/R circuit. It is 
reported that las-mediated QS inhibits the production of exopolysaccharide, Pel, 
which builds the biofilm matrix [34].
Another element controlled by QS in P. aeruginosa biofilm development is 
rhamnolipids production [35]. These biosurfactant rhamnolipids caused bacterial 
detachment of Pseudomonas biofilms or even biofilms produced by other microor-
ganisms (Bordetella bronchiseptica and C. albicans) [36].
In Staphylococcus aureus, Agr is a QS regulation system [37]. It was demonstrated 
in S. aureus that a specific class of secreted peptides (phenol-soluble modulins, 
PSMs) that have surfactant-like properties mediates the main impact of Agr in 
biofilm dispersion. PSM operons transcription is under strict control by AgrA and 
agr mutants lack PSM production [38]. Also, it is shown that by analysis of biofilm 
tridimensional structure with confocal laser scanning microscopy, PSMs impacted 
the biofilm volume, thickness, roughness, and channel formation.
2.6 Efflux pumps
Efflux pumps are membrane proteins that are related to the export of harmful 
substances from within the bacterial cell into the external environment. They are 
found in all species of bacteria, and efflux pump genes can be found in bacte-
rial chromosomes or mobile genetic elements, such as plasmids. A wide array of 
substrates, such as antibiotics, detergents, dyes, toxins, and waste metabolites are 
extruded by efflux pumps [39].
There are five known different classes of bacterial efflux pumps, which are the 
major facilitator superfamily (MF), the small multidrug resistance family (SMR), 
the ATP-binding cassette family (ABC), the resistance nodulation-division family 
(RND), and the multidrug and toxic compound extrusion family (MATE) [40]. To 
carry out the antimicrobial agent flow, the ABC family system hydrolyzes the ATP 
Figure 1. 
Stages of bacterial biofilm formation ((a) Planktonic cells adhere to a surface, (b) Initial attachment; cell 
proliferates to form a monolayer over the surface, (c–d) Increase in cell numbers results in the synthesis of 
elevated levels of autoinducers and EPS, (e) A mature biofilm with increased resistance to hostile 
environmental factors, (f) Dispersion of bacteria,  : Autoinducers,  : eDNA,  : Enzymes).
Bacterial Biofilms
6
while the MF family, the MATE family, and the RND family act as secondary carriers 
and catalyze the drug ion antiproton [41].
Efflux pumps play a role in the natural resistance to antibiotics in some patho-
gens. These pumps also cause acquired resistance by overexpression and contribute 
to other resistance mechanisms [20]. Overproduction of the efflux pump can lead to 
multidrug resistance. Bacterial efflux pumps perform multidrug resistance (MDR) 
phenotype [42]. The efflux pump slows down the diffusion of hydrophilic solutes 
by downregulating the “porin” production in several pathogenic bacteria, such as 
E. coli, Enterobacter aerogenes, and Klebsiella pneumonia, thereby decreasing the 
transmembrane diffusion of lipophilic solutes [43].
Some multidrug efflux pumps contribute significantly to biofilm formation and 
this mechanism can be used to help bacteria overcome attacks from several classes 
of antibiotics. Extremely reduced biofilm formation has been reported for mutant 
E. coli that does not have the various genes associated with efflux pumps [44].
Upregulation of some efflux pumps (MexAB-OprM and MexCD-OprJ) in 
resistant P. aeruginosa biofilms has been observed in the presence of azithromycin 
[45]. It is reported that flow pump PA 1874-1877 is associated with biofilm-specific 
resistance to antibiotics.  When these genes are mutated, lower resistance to amino-
glycosides and fluoroquinolones is seen in biofilm conditions [46].
Efflux pumps may play different roles in biofilm formation; several studies 
proposed that efflux of EPSs and QS molecules to facilitate biofilm matrix forma-
tion and regulate QS, respectively, lead to indirect regulation of genes involved in 
biofilm formation and influence aggregation by promoting or preventing adhesion 
to surfaces and other cells [39].
2.7 Genetic diversity
Genetic diversity provides bacterial adaptation, evolution, and survival in 
hostile environments. Biofilms are considered as a reservoir of genetic diversity. 
In biofilms, the emergence and spread of antibiotic resistance genes increase with 
horizontal gene transfer (HGT). HGT can happen through the transfer of plasmids 
among microorganism cells in a biofilm by conjugation. Actually, studies that are 
practiced by certain researchers have demonstrated that plasmid moving among 
bacterial cells might be more effective in biofilms than planktonic cells and that 
probably arises from proximity of microorganism cells in planktonic shape. In 
addition, some bacteria have the ability to pick up DNA from the biofilm matrix. 
The highly hydrated matrix provides favorable conditions for natural transforma-
tion [47]. Incidence of antibiotic resistance gene cassettes is determined more than 
100-fold higher in biofilms than in planktonic cells [48].
Mutation frequency can be another factor that increases antibiotic resistance or 
tolerance. There is proof in the literature that cells in biofilms accumulate mutations 
at a higher rate than planktonic cells and these mutations may contribute to increase 
of antibiotic resistance [16]. Some bacteria have ability to pick up DNA from the 
biofilm matrix in addition.
2.8 Multispecies interactions
Many laboratory studies about biofilm associated with antibiotic resistance and 
tolerance mechanisms have focused on monospecies biofilms in the literature and 
this issue is becoming progressively apparent. Interactions among microorganisms 
that are different species in a biofilm can alter the general antimicrobial resistance 
of the population. When we regard that many infections are polymicrobial, these 
interactions may be considered clinically important [49].
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Studies are showing that antimicrobial resistance in multispecies biofilms is 
much higher than that in monospecies biofilms in available literature. For instance, 
it is determined that in vivo P. aeruginosa growing in a monospecies biofilm is twice 
more vulnerable to gentamicin antibiotic than that growing in multispecies biofilm 
consisting of S. aureus, Enterococcus faecalis, and Finegoldia magna. The molecular 
mechanism that underlies this multispecies biofilm model, which increases genta-
micin tolerance, is not known [50].
A clinically important model of multispecies biofilm infection includes Moraxella 
catarrhalis and Streptococcus pneumoniae. These bacteria play a role in the pathogen-
esis of otitis media, a biofilm-mediated infection that may be multi microbial. When 
antibiotic therapy is required, otitis media is commonly treated by amoxicillin. 
However, in stubborn cases, second-line treatments, such as amoxicillin-associated 
β-lactamase inhibitor or azithromycin, are applied. It is determined that in the 
biofilm consisting of two species, M. catarrhalis produces β-lactamase that provides 
resistance of S. pneumoniae against amoxicillin. Reciprocally, S. pneumoniae protects 
M. catarrhalis from azithromycin with an unknown mechanism [51].
Interactions between different microorganisms and their effects on biofilm 
susceptibility to antibiotics have also been examined in polymicrobial biofilms. C. 
albicans, an opportunistic fungal pathogen, and S. aureus have a high resistance to 
vancomycin in a dual species. In a biofilm that is composed of C. albicans and S. 
aureus, S. aureus is associated with the fungal hyphae via the C. albicans Als3p adhesin 
and becomes covered with biofilm matrix probably derived from C. albicans [52].
Owing to the fungal matrix component, β-1,3-glucan, which is thought to act 
as a barrier to vancomycin diffusion into the biofilm, Staphylococcal resistance to 
vancomycin is increased in polymicrobial biofilms formed with C. albicans [53].
In polymicrobial biofilms, molecular basis may increase antibiotic resistance. In 
a study focused on P. aeruginosa and S. maltophilia two-species biofilm, it is deter-
mined that an intercellular signaling molecule that is secreted by S. maltophilia is 
sensed by the two-component sensor, BptS in P. aeruginosa, inducing upregulation 
of the PmrA-regulated PA3552–3559 and PA4773–4775 genes. These two operon 
gene products provide resistance to polymyxins, which is a cationic antimicrobial 
peptide. Actually, P. aeruginosa cultured in a biofilm with S. maltophilia have 
reduced vulnerability to polymyxin B and colistin compared to P. aeruginosa, 
single-species biofilms [54].
3. Approaches aimed at overcoming biofilm resistance
Biofilm infections can be treated and dispersed by the mixture of traditional 
antibiotics and  substances called biofilm disrupting. The dissolution of biofilm 
is the first step in the ability of the host organism’s immune system to remove 
microbial pathogens [55]. The combined antibiotics with the biofilm-dispersing 
medicines can bring a promising outcome. Most biofilm-dispersing medicines do 
not kill the pathogenic cells when they are used alone. For instance, patulin was 
analyzed with the aim of acyl-homoserine lactone removal in P. aeruginosa, but it 
had no effect on the existence of P. aeruginosa cells in a given biofilm. Although 
only patulin had no effect on the P. aeruginosa, the combination of patulin with 
antibiotic tobramycin was more effective and caused serious killing of the bacte-
rial cells [56]. Another study showed that the mixture of the quorum controlling 
compounds with the antibiotic tigecycline increased the susceptibility of S. aureus 
fourfold compared to tigecycline alone [57]. Furthermore, the treatment of S. 
aureus with the mixture of cis-2-decenoic acid and ciprofloxacin is improved from 
11 to 87% compared to antibiotic alone.
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Considering the rising number of antibiotic-resistant pathogens, QS inhibitors 
can be used as a mixture with the remaining sensitive antibiotics to complement 
their effects. These molecules mainly act by suppressing the QS system, and their 
practice with antibiotics leads to effective cure at much lower dosages of the drug 
than necessary, which may result in reduced therapeutic costs. These combina-
tions can be beneficial in the cure of chronic infections, such as chronic urinary 
tract, cystic fibrosis, or prosthetic infections and biofilms are a barrier to antibi-
otic diffusion in these chronic diseases.
There is an urgent need for new methods in the cure of biofilm-associated infec-
tions. For instance, cyclic di-GMP (c-di-GMP) is a commonly protected prokaryotic 
second messenger signal molecule necessary for biofilm development [58]. New 
inhibitors of diguanylate cyclase enzymes were identified by using in silico screen-
ing, and they tested them successfully in vitro. Inhibitors of flow pumps can also 
be recommended to complement the effect of antimicrobial agent and needed to be 
tested in vivo.
The choice of antimicrobial agents also seems to be significant because some 
of them may act as agonists for biofilm formation and some may disrupt it. The 
usage and dosages of novel antibiotics should be checked and clinically synthe-
sized antibiotics should be tested at impactful concentrations by considering their 
distribution in biofilms and the detrimental effects of signaling molecules. Other 
compounds act as key enzymes in the biosynthesis of these signaling molecules 
and play a role in regulating virulence factor production and biofilm formation. A 
ligand-based strategy will allow the identification of new inhibitors in the future.
Better usage of the new active molecules can be supported by understanding 
mechanisms of antimicrobial agents activity as well as the molecular mechanisms 
associated with biofilm formation and recalcitrance [5].
4. Conclusion
Biofilm infections are highly resistant to antibiotics and physical treatments and 
it is known that there are many strategies that support biofilm antibiotic resistance 
and tolerance, such as persistent cells, adaptive responses, and limited antibiotic 
penetration. It is also known that the underlying mechanisms of antibiotic tolerance 
and resistance in biofilms have a genetic basis in many cases.
In human diseases, highly organized bacterial cells gradually induce immune 
responses to form biofilms responsible for chronic infections that lead to tissue 
damage and permanent pathology. Therefore, the formation of biofilm is consid-
ered a critical concern in health care services.
Exploring promising cure methods for biofilm-associated infections is an 
urgent task. Few innovative and effective antibiotic strategies have been tried, 
such as dispersion of biofilms, antibiotic combinations with quorum sensing 
inhibitors, and a mixture of all these new techniques. Although the mentioned 
anti-biofilm strategies are important research areas, they are still in infancy and 
have not undergone clinical research and entered the commercial market. We 
hope that new anti-biofilm molecules based on finding universal substances that 
do not harm cells and synergistic with commonly used antibiotics will be available 
in the near future.
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